Many readers will know of the ongoing lawsuit against GSK in the UK. The group action claims that Seroxat, GSK's antidepressant, caused withdrawal difficulties in a number of people taking it. This the Company has now admitted through its Patient Information Leaflets.
What isn't known by many, Hugh James of Cardiff, wrote to litigants roughly about two years ago urging them to discontinue the case against GSK. Myself and many others disagreed and, behind the scenes, we have sought advice and other representation.
With the assistance of the Legal Services Commission (LSC) – the funding agency, we now seem to be heading back on track. The LSC have never pulled funding for this litigation but have re-examined its merit especially with fewer people remaining in the group action after Hugh James’ advice to discontinue.
